Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03955250 · ClinicalTrials.gov registry record · NA

Mobile After-Care Support App: Pilot RCT

A NA study of Psychotic Disorder, sponsored by Butler Hospital.

Completed
Registry status
NA
Development phase
42
Enrollment target
1
Study location

NCT03955250 is a NA study of Psychotic Disorder that has completed, run by Butler Hospital. The registered enrollment target is 42 participants, below the 335-participant average among 5 other Psychotic Disorder trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03955250, a NA study of Psychotic Disorder, has completed, sponsored by Butler Hospital.

COMPLETED
Registry status
NA
Development phase
42 participants
Enrollment target
1
Study location

Study Summary

The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-spectrum disorder. The purpose of the proposed project is to establish the feasibility, acceptability, and preliminary effects of the app. To achieve the specific aims, the investigators will conduct a pilot randomized clinical trial (n = 60), with two treatment arms: MACS vs. a mobile app attention control condition.

Conditions Studied

Interventions

  • BEHAVIORAL Mobile After-Care Support (MACS) app
  • BEHAVIORAL Mobile app attention control

Study Locations (1)

Rhode Island

  • Butler Hospital - Providence

Trial Details

FieldValue
Enrollment Target 42 participants
Start Date 2019-05-31
Est. Completion 2022-05-31
Phase NA

Sponsor

Butler Hospital

103 total trials

What the Registry Record Tells You About NCT03955250

The ClinicalTrials.gov registry entry for NCT03955250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 42 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 335-participant average among 5 other Psychotic Disorder trials with a reported enrollment target (87% lower). The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Psychotic Disorder appearing as the primary indexed condition, and to 2 interventions - of which Mobile After-Care Support (MACS) app is the first listed.

NCT03955250 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.

Frequently Asked Questions

What is clinical trial NCT03955250 about?

NCT03955250 is a clinical study titled "Mobile After-Care Support App: Pilot RCT". The overall aim of this program of research is to refine and test the feasibility and acceptability of a newly developed mobile device-delivered app, called Mobile After-Care Support (MACS), to improve patients' coping and treatment adherence following a hospitalization related to their psychotic-sp...

What is the current status of trial NCT03955250?

This trial is currently completed. It is a NA study. The enrollment target is 42 participants. The study started on 2019-05-31. Estimated completion is 2022-05-31.

What conditions does trial NCT03955250 study?

This clinical trial studies the following conditions: Psychotic Disorder.

What interventions are being tested in trial NCT03955250?

The interventions under investigation include: Mobile After-Care Support (MACS) app (BEHAVIORAL), Mobile app attention control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03955250?

This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03955250 being conducted?

This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Psychotic Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.